Lufthansa Won't Appoint New CEO Until Next Year
Roxgold reports financial results for period ended September 30, 2013
Ventana presents CareGiver remote support at 2013 DreamForce
Roche Gets EU Approval For Breast Cancer Drug
These quality funds with smaller asset bases have portfolios built around solid companies.
Large drugmakers are out of favor, but some good funds are banking on a rebound.
As incomes rise, emerging-markets consumers can afford more and better medications driving attractive growth in the pharmaceuticals sector, say the managers of Dodge & Cox International Stock.